Trader builds huge position on Sun Pharma F&O counter
The call at the 460 strike has the third-highest OI of a little over 20 lakh shares.

What Client 1 did with his exposure on Thursday (December 6) and whether his bets are bullish, bearish or a hedge is hard to tell. But, near-month options of Sun Pharma peg a strong support at Rs 400 and stiff resistances at Rs 460, Rs 480 and Rs 500.
Derivatives experts like Rajesh Palviya of Axis Securities believe that buying Sun at Thursday’s close of Rs 417.55 for a target of Rs 460 and stop loss of Rs 400 is an expedient strategy.
Stock options expiring on December 27 fit in with this view as the 400 strike put has the highest open interest of 24.89 lakh shares. The call at the 460 strike has the third-highest OI of a little over 20 lakh shares. The strategy has a risk -reward of around 2:1.
NSE data show that on December 4, Client 1 held 3.24 per cent of MWPL, which itself was 21,88,93,858 crore (21.88 crore). In absolute terms, the client held around 70.92 lakh shares of MWPL, a sizeable derivatives position.

The average daily traded volumes from December 3 through December 6 were Rs 2,216 crore, a huge quantity compared with the three-month daily average of Rs 502 crore, indicating the punting interest in the stock. The daily delivery to traded quantity was 32.04 per cent against the three-month average of 33.86 per cent.
Download ET Markets APP